Anticancer effects of imidazole nucleus in hepatocellular carcinoma cell lines via the inhibition of AKT and ERK1/2 signaling pathways.

Published in: Molecular biology reports (2022)

The findings of this present study established the anti-cancer effects of imidazole nucleus in HCC cell lines and showed that it could be a potential molecule in the treatment of HCC via inhibition of AKT and ERK1/2 signaling pathways.

Keyphrases

signaling pathway
pi k akt
induced apoptosis
epithelial mesenchymal transition
cell proliferation
risk assessment
climate change